Clinical Trial Update: Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of zoledronic acid on circulating and bone marrow–residing prostate cancer cells in men with clinically localized…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED